JFS Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43K | Sell |
26
-44
| -63% | -$2.42K | ﹤0.01% | 1480 |
|
|
2025
Q1 | $4.95K | Buy |
70
+11
| +19% | +$778 | ﹤0.01% | 1133 |
|
|
2024
Q4 | $3.88K | Sell |
59
-35
| -37% | -$2.3K | ﹤0.01% | 1218 |
|
|
2024
Q3 | $6.61K | Buy |
94
+16
| +21% | +$1.13K | ﹤0.01% | 1013 |
|
|
2024
Q2 | $6.42K | Sell |
78
-5
| -6% | -$412 | ﹤0.01% | 959 |
|
|
2024
Q1 | $7.25K | Sell |
83
-8
| -9% | -$699 | ﹤0.01% | 935 |
|
|
2023
Q4 | $8.78K | Buy |
91
+5
| +6% | +$482 | ﹤0.01% | 814 |
|
|
2023
Q3 | $7.61K | Hold |
86
| – | – | ﹤0.01% | 820 |
|
|
2023
Q2 | $7.46K | Sell |
86
-5
| -5% | -$433 | ﹤0.01% | 833 |
|
|
2023
Q1 | $8.85K | Sell |
91
-5
| -5% | -$486 | ﹤0.01% | 754 |
|
|
2022
Q4 | $9.94K | Buy |
96
+7
| +8% | +$724 | ﹤0.01% | 717 |
|
|
2022
Q3 | $8K | Buy |
89
+8
| +10% | +$719 | ﹤0.01% | 792 |
|
|
2022
Q2 | $7K | Buy |
81
+18
| +29% | +$1.56K | ﹤0.01% | 858 |
|
|
2022
Q1 | $5K | Buy |
63
+13
| +26% | +$1.03K | ﹤0.01% | 1022 |
|
|
2021
Q4 | $4K | Sell |
50
-1,040
| -95% | -$83.2K | ﹤0.01% | 832 |
|
|
2021
Q3 | $84K | Buy |
+1,090
| New | +$84K | 0.01% | 341 |
|
|
2015
Q3 | – | Sell |
-24
| Closed | -$3K | – | 487 |
|
|
2015
Q2 | $3K | Sell |
24
-14
| -37% | -$1.75K | ﹤0.01% | 442 |
|
|
2015
Q1 | $5K | Sell |
38
-10
| -21% | -$1.32K | ﹤0.01% | 412 |
|
|
2014
Q4 | $4K | Sell |
48
-1
| -2% | -$83 | ﹤0.01% | 444 |
|
|
2014
Q3 | $4K | Sell |
49
-7
| -13% | -$571 | ﹤0.01% | 392 |
|
|
2014
Q2 | $3K | Buy |
+56
| New | +$3K | ﹤0.01% | 407 |
|